Olgu Sunumu
BibTex RIS Kaynak Göster

Mondor’s disease of the breast; Case report.

Yıl 2017, Cilt: 1 Sayı: 1, 18 - 20, 15.04.2017
https://doi.org/10.28982/josam.337794

Öz

Mondor's disease is sclerosing thrombophlebitis at anterior
chest wall. It was first described by Henri Mondor in 1939. Despite the use of
antibiotics, steroids, anticoagulants, no significant benefit was found.
Symptomatic measures are sufficient for treatment. Mondor's disease is a
self-limiting disease. Improvement is seen between 3 weeks and 6 months. In
these cases, investigations should be done for hidden cancers in other region
of the breast. In this study, a case with this rare disease was discussed in
the context of the literature.

Kaynakça

  • 1. Camargo Jr HSA, Camargo MMA, Teixeira SRC. Doença de Mondor: apresentação de três casos com características clínicas distintas. Rev Bras Mastologia. 2003;13(4):175-8.
  • 2. Mondor H. Tronculite sous-cutanée subaigue de la paroi thoracique antéro-latérale. Mem Acad Chir. 1939;65(28):1271-8.
  • 3. Niechajev I. Mondor's subcutaneous banding after transaxillary breast augmentation: case report and the review of literature. Aesthetic Plast Surg. 2013;37(4):767-9.
  • 4. Coscia J, Lance S, Wong M, Garcia J. Mondor's thrombophlebitis 13 years after breast augmentation. Ann Plast Surg. 2012;68(4):336-7. [ Links ]
  • 5. Khan UD. Mondor disease: a case report and review of the literature. Aesthet Surg J. 2009;29(3):209-12. [ Links ]
  • 6. Hasbahceci M, Erol C, Seker M. Image of the month. Mondor disease. Arch Surg. 2012;147:197-8.
  • 7. Cesarone MR, Belcaro G, Agus G, Georgiev M, Errichi BM, Marinucci R, et al. Management of superficial vein thrombosis and thrombophlebitis: Status and expert opinion document. Angiology 2007;58 Suppl 1:7S-14.
  • 8. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):454S-545S.
  • 9. Lee JT, Kalani MA. Treating superficial venous thrombophlebitis. J Natl Compr Canc Netw 2008;6:760-5.

Memenin Mondor hastalığı; Olgu sunumu.

Yıl 2017, Cilt: 1 Sayı: 1, 18 - 20, 15.04.2017
https://doi.org/10.28982/josam.337794

Öz

Mondor hastalığı
anterior göğüs duvarı yüzeyel venlerinin sklerozan tromboflebitidir. İlk kez
1939 yılında Henri Mondor tarafından tanımlanmıştır. Tedavisinde antibiyotik,
steroid, antikoagulanlar kullanılmış fakat belirgin bir yarar saptanmamıştır.
Semptomatik önlemler tedavide yeterlidir. Mondor hastalığı kendi kendini
sınırlayan selim bir hastalıktır. Üç hafta ile 6 ay arasında iyileşme görülür.
Bu olgularda diğer bölgelerde olabilecek gizli kanserler için araştırmalar
yapılmalıdır. Bu çalışmada çok nadir görülen bu hastalığı bir olgu nedeniyle
literatür eşliğinde tartıştık.

Kaynakça

  • 1. Camargo Jr HSA, Camargo MMA, Teixeira SRC. Doença de Mondor: apresentação de três casos com características clínicas distintas. Rev Bras Mastologia. 2003;13(4):175-8.
  • 2. Mondor H. Tronculite sous-cutanée subaigue de la paroi thoracique antéro-latérale. Mem Acad Chir. 1939;65(28):1271-8.
  • 3. Niechajev I. Mondor's subcutaneous banding after transaxillary breast augmentation: case report and the review of literature. Aesthetic Plast Surg. 2013;37(4):767-9.
  • 4. Coscia J, Lance S, Wong M, Garcia J. Mondor's thrombophlebitis 13 years after breast augmentation. Ann Plast Surg. 2012;68(4):336-7. [ Links ]
  • 5. Khan UD. Mondor disease: a case report and review of the literature. Aesthet Surg J. 2009;29(3):209-12. [ Links ]
  • 6. Hasbahceci M, Erol C, Seker M. Image of the month. Mondor disease. Arch Surg. 2012;147:197-8.
  • 7. Cesarone MR, Belcaro G, Agus G, Georgiev M, Errichi BM, Marinucci R, et al. Management of superficial vein thrombosis and thrombophlebitis: Status and expert opinion document. Angiology 2007;58 Suppl 1:7S-14.
  • 8. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):454S-545S.
  • 9. Lee JT, Kalani MA. Treating superficial venous thrombophlebitis. J Natl Compr Canc Netw 2008;6:760-5.
Toplam 9 adet kaynakça vardır.

Ayrıntılar

Konular Cerrahi
Bölüm Olgu sunumu
Yazarlar

Yahya Kemal Çalışkan

Yayımlanma Tarihi 15 Nisan 2017
Yayımlandığı Sayı Yıl 2017 Cilt: 1 Sayı: 1

Kaynak Göster

APA Çalışkan, Y. K. (2017). Mondor’s disease of the breast; Case report. Journal of Surgery and Medicine, 1(1), 18-20. https://doi.org/10.28982/josam.337794
AMA Çalışkan YK. Mondor’s disease of the breast; Case report. J Surg Med. Nisan 2017;1(1):18-20. doi:10.28982/josam.337794
Chicago Çalışkan, Yahya Kemal. “ Case Report”. Journal of Surgery and Medicine 1, sy. 1 (Nisan 2017): 18-20. https://doi.org/10.28982/josam.337794.
EndNote Çalışkan YK (01 Nisan 2017) Mondor’s disease of the breast; Case report. Journal of Surgery and Medicine 1 1 18–20.
IEEE Y. K. Çalışkan, “ Case report”., J Surg Med, c. 1, sy. 1, ss. 18–20, 2017, doi: 10.28982/josam.337794.
ISNAD Çalışkan, Yahya Kemal. “ Case Report”. Journal of Surgery and Medicine 1/1 (Nisan 2017), 18-20. https://doi.org/10.28982/josam.337794.
JAMA Çalışkan YK. Mondor’s disease of the breast; Case report. J Surg Med. 2017;1:18–20.
MLA Çalışkan, Yahya Kemal. “ Case Report”. Journal of Surgery and Medicine, c. 1, sy. 1, 2017, ss. 18-20, doi:10.28982/josam.337794.
Vancouver Çalışkan YK. Mondor’s disease of the breast; Case report. J Surg Med. 2017;1(1):18-20.